United States
Print page content Print
Increase text size Decrease text size
Text Size

ENVIRACOR™ J-5

Help protect your herd with the total package. Demonstrated safety and efficacy.

Dry off isn’t complete without vaccinating against Escherichia coli (E. coli) mastitis. As the No. 1 E. coli mastitis vaccine,1 ENVIRACOR J-5 provides a safe and effective way to help control clinical signs associated with E. coli mastitis. Vaccinating against E. coli mastitis helps lessen the severity of cases of E. coli mastitis and helps provide an opportunity for successful treatment.

The best way to knock out mastitis during the dry period is to implement a comprehensive milk quality program that focuses on treatment and prevention. Visit www.milkqualityfocus.com/drycow to hear from dairy producers and veterinarians who have seen the benefits from investing in comprehensive dry cow management. It pays dividends through improved milk quality and is the right thing for their herd and their operation.

1BeaconMR™ Q4 2011 MAT.

Expand All
    • The three-dose regimen helps stimulate the immune system for optimum response to help control clinical signs associated with E. coli mastitis
    • Shortens duration of E. coli mastitis by 41 percent (64 hours) when compared with control cows,2 allowing you to return to salable milk production more quickly
    • Increases antibody titers in milk by 13 times2
    • Particularly valuable in recently freshened, low-SCC and high-production cows, which may be more susceptible to E. coli mastitis.

    2Data on file, Study Report No. 3931-60-08-562, Zoetis Inc.

  • ENVIRACOR™ J-5 should be administered in a three-injection regimen. Vaccinate cows or heifers with a 5 mL dose at 7 and 8 months of gestation followed by the third dose within two weeks postpartum.

    ENVIRACOR™ J-5 is available in 100-mL (20-dose) and 250-mL (50-dose) vials.